共 176 条
[1]
Larsen T(2016)Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study BMJ 353 i3189-97
[2]
Skjøth F(2013)Anticoagulants: a review of the pharmacology, dosing, and complications Curr Emerg Hosp Med Rep 1 83-544
[3]
Nielsen P(2007)The safety of warfarin therapy in the nursing home setting Am J Med 120 539-321
[4]
Kjældgaard J(2015)Evaluation of dabigatran- and warfarin-associated hemorrhagic events using the FDA-adverse event reporting system database stratified by age Int Med Sci 12 312-569
[5]
Lip G(2013)Bleeding complications associated with warfarin treatment in ischemic stroke patients with atrial fibrillation: a population-based cohort study J Stroke Cerebrovasc Dis 22 561-243
[6]
Alquwaizani M(2016)Quality of anticoagulation control among patients with atrial fibrillation: an experience of a tertiary care center in Saudi Arabia J Saudi Heart Assoc 28 239-560
[7]
Buckley L(2010)Trends of adverse drug reactions related-hospitalizations in Spain (2001–2006) BMC Health Serv Res 10 287-268
[8]
Adams C(1995)How to do it: service provision and use of anticoagulants in atrial fibrillation BMJ 311 558-1291
[9]
Fanikos J(1996)Methods for managing the increased workload in anticoagulant clinics [letter] BMJ 312 286-34
[10]
Gurwitz J(2014)Implementation of pharmacist-managed anticoagulation clinic in a Saudi Arabian health center Hosp Pharm 49 260-16